Literature DB >> 7697128

Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).

S Wilk1, M E Figueiredo-Pereira.   

Abstract

Synthetic inhibitors of the multicatalytic proteinase complex (proteasome) can provide the means to uncover the functional significance and catalytic mechanism of this macromolecule. Although inhibitor development is still in its early stages, some useful compounds have already been prepared. Of the various types of inhibitors thus far studied, peptidyl aldehydes have been the most effective. Since peptidyl aldehydes inhibit both serine and cysteine proteinases, lack of specificity is their major limitation. The properties of one such compound N-benzyloxycarbonyl-IE(Ot-Bu)A-Leucinal, a potent inhibitor of suc-LLVY-MCA hydrolysis, are described in detail.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7697128     DOI: 10.1159/000468688

Source DB:  PubMed          Journal:  Enzyme Protein        ISSN: 1019-6773


  13 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  Synthetic peptide-based activators of the proteasome.

Authors:  S Wilk; W E Chen
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

3.  Are proteasomes involved in the formation of the kinetochore?

Authors:  N Paweletz; C Wójcik; D Schroeter; E M Finze
Journal:  Chromosome Res       Date:  1996-09       Impact factor: 5.239

Review 4.  Biochemical properties of insect and crustacean proteasomes.

Authors:  D L Mykles
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

5.  Activation of the cell death program by inhibition of proteasome function.

Authors:  H C Drexler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

6.  Inhibition of hepatitis B virus replication by interferon requires proteasome activity.

Authors:  Michael D Robek; Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences.

Authors:  J C Betts; G J Nabel
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

8.  Modulators of the activation of the proteasome by PA28 (11S reg).

Authors:  S Wilk; W E Chen; R P Magnusson
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

9.  Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons.

Authors:  R Sadoul; P A Fernandez; A L Quiquerez; I Martinou; M Maki; M Schröter; J D Becherer; M Irmler; J Tschopp; J C Martinou
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

Review 10.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.